An Australian team used Pacific Biosciences long reads, 10X Genomics linked reads, and Bionano Genomics mapping to assemble a desert dingo genome de novo.
Among the firms reporting, BGI talked about plans to cut down the time and cost of its WGS service, and Invitae's CEO made a surprising proclamation about genetic testing.
More than a third of NGS users plan to purchase a new sequencing system within a year, according to the survey, conducted by GenomeWeb and investment bank William Blair.
The Index underperformed the Dow, Nasdaq, and Nasdaq Biotechnology Index, reversing gains it had made in October and November.
The Index significantly outperformed the Dow, Nasdaq, and Nasdaq Biotechnology Index as it showed double the growth that it had displayed in October.
The firm recently hired Kathy Ordoñez as chief commercial officer, who plans to develop clinical opportunities for the company.
The company's product revenues increased over the prior year period, although total revenues missed analysts' average forecast.
The firms will combine PacBio's single-molecule sequence data and de novo assembly with Bluebee's cloud-based genomics analysis platform.
In 2015, the iBOL project met its initial milestone of generating barcode sequences for 500,000 animal, plant, and fungal species.
In its suit PacBio alleges that Oxford Nanopore infringes two patents it holds related to nanopore sequencing.
At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.
The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.
Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.
In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.